BlackRock »

Autolus Therapeutics Plc spon ads shares owned by BlackRock

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by BlackRock

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.7M 3.5M 1.63
2025-06-30 $8.0M 3.5M 2.28
2025-03-31 $6.1M 3.9M 1.55
2024-12-31 $9.7M 4.1M 2.35
2024-09-30 $16M 4.4M 3.63

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)
Netflix (NFLX)

View all positions for BlackRock

Top funds holding Autolus Therapeutics Plc spon ads

MAK Capital One
Blackstone Group
Syncona Portfolio
Armistice Capital
Polygon Management
Schroder Investment Management Group
Citadel Advisors
Renaissance Technologies
Frazier Life Sciences Management
BlackRock
AXA Investment Managers
Laurion Capital Management
Deep Track Capital
Acadian Asset Management
Affinity Asset Advisors

View all funds holding Autolus Therapeutics Plc spon ads